Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids

NCT: NCT06106269 · RECRUITING

NCT IDNCT06106269
StatusRECRUITING
Start Date2024-06-07
Completion2026-12
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.

Frequently Asked Questions

What is Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids?

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids is a clinical trial registered under NCT06106269. Current status: RECRUITING.

What is the status of NCT06106269?

The current status of NCT06106269 (Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids) is: RECRUITING.

When did Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids start?

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids started on 2024-06-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑